[HTML][HTML] Assessment of quality of life following allogeneic stem cell transplant for myelofibrosis
J Palmer, HE Kosiorek, C Wolschke… - Biology of Blood and …, 2019 - Elsevier
Patient-reported outcomes (PROs) for patients with myelofibrosis (MF) have been well
characterized, but little is known about quality of life (QoL) following allogeneic stem cell …
characterized, but little is known about quality of life (QoL) following allogeneic stem cell …
Myeloproliferative Neoplasm Quality of Life (MPN-QOL) Study Group: observational study of quality of life and symptomatic response in myelofibrosis patients …
V Fauble, RM Emanuel, HL Geyer, AC Dueck… - 2013 - ashpublications.org
Abstract Introduction Myelofibrosis (MF) and Post PV/ET MF represents a group of
debilitating hematological disorders in which quality of life (QOL) is severely compromised in …
debilitating hematological disorders in which quality of life (QOL) is severely compromised in …
[HTML][HTML] Dynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic …
M Ditschkowski, AH Elmaagacli, R Trenschel… - …, 2012 - ncbi.nlm.nih.gov
Background Myelofibrosis is a myeloproliferative stem cell disorder curable exclusively by
allogeneic hematopoietic stem cell transplantation and is associated with substantial …
allogeneic hematopoietic stem cell transplantation and is associated with substantial …
[HTML][HTML] Patient perspectives regarding allogeneic bone marrow transplantation in myelofibrosis
J Palmer, R Scherber, M Girardo, H Geyer… - Biology of Blood and …, 2019 - Elsevier
Hematopoietic stem cell transplantation (HCT) is a curative treatment for patients with
myelofibrosis (MF); however, many HCT-eligible patients decline this potentially life-saving …
myelofibrosis (MF); however, many HCT-eligible patients decline this potentially life-saving …
[HTML][HTML] Predicting survival after allogeneic hematopoietic cell transplantation in myelofibrosis: performance of the Myelofibrosis Transplant Scoring System (MTSS) …
JC Hernández-Boluda, A Pereira… - Biology of Blood and …, 2020 - Elsevier
Accurate prognostic tools are crucial to assess the risk/benefit ratio of allogeneic
hematopoietic cell transplantation (allo-HCT) in patients with myelofibrosis (MF). We aimed …
hematopoietic cell transplantation (allo-HCT) in patients with myelofibrosis (MF). We aimed …
Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis
Factors predicting allogeneic hematopoietic cell transplantation (HCT) outcomes in
myelofibrosis in the early post-HCT period have not been defined thus far. We attempt to …
myelofibrosis in the early post-HCT period have not been defined thus far. We attempt to …
Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis
H Alchalby, DR Yunus, T Zabelina, F Ayuk… - Bone Marrow …, 2016 - nature.com
Allogeneic hematopoieteic stem cell transplantation (HSCT) is the only curative treatment for
myelofibrosis (MF), but it is still associated with significant risks and complications. One of …
myelofibrosis (MF), but it is still associated with significant risks and complications. One of …
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis
R Tamari, DP McLornan, KW Ahn… - Blood …, 2023 - ashpublications.org
To develop a prognostic model for patients undergoing allogeneic hematopoietic cell
transplantation (allo-HCT) for myelofibrosis (MF), we examined the data of 623 patients …
transplantation (allo-HCT) for myelofibrosis (MF), we examined the data of 623 patients …
The Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in …
Quality of life (QoL) in patients with myelofibrosis (MF) is severely compromised by severe
constitutional symptoms (ie fatigue, night sweats, fever, weight loss), pruritus, and symptoms …
constitutional symptoms (ie fatigue, night sweats, fever, weight loss), pruritus, and symptoms …
[HTML][HTML] Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
M Robin, LC De Wreede, C Wolschke, J Schetelig… - …, 2019 - ncbi.nlm.nih.gov
Allogeneic hematopoietic stem cell transplant remains the only curative treatment for
myelofibrosis. Most post-transplantation events occur during the first two years and hence …
myelofibrosis. Most post-transplantation events occur during the first two years and hence …